Institutional investors control 48.45% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2013, these large investors purchased a net $25.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 16.0 Million shares of Geron Corp
CREATIVE PLANNING, INC. Bought 4.5 Thousand shares of Geron Corp
PRENTISS SMITH & CO., INC. Sold 1.0 Thousand shares of Geron Corp